Lupin Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Lupin Launches Rivaroxaban for Oral Suspension in the United States".
Lupin Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Lupin Launches Rivaroxaban for Oral Suspension in the United States".